Table 1.

Demographics of patients infected/colonized with OXA-48-like-producing Enterobacteriaceae

Case no.	Age (yr)/sexa	Diagnosisb	Comorbidityc	Prior hospitalization (no. of days)	Species	Sourced	Datee of first isolation	Directed therapyf	Outcome
1	45/M	PVD and sepsis	DM, HT, RF	2	K. pneumoniae	Tissue	05/08/2011	Colistin and tigecycline	Deceased
2	29/M	80% burns	None	3	K. pneumoniae	TA	16/01/2012	Colistin and meropenem	Deceased
3	51/F	68% burns	None	28	S. marcescens	Tissue	19/12/2011	None (debridement)	Recovered
4	55/F	Spinal stenosis	DM, morbid obesity	12	K. pneumoniae	Urine	23/01/2012	None (pt already discharged)	Recovered
5	6/F	UTI	None	13	K. pneumoniae	Urine	05/03/2012	None (pt already discharged)	Recovered
6	82/M	CVA	RF	20	K. pneumoniae	TA	16/12/2012	None (pt died the following day)	Deceased
7	87/F	Collapse and resuscitation	RF	34	K. pneumoniae	Urine	09/02/2012	None (pt died the following day)	Deceased
8	74/M	Terminal lung CA	DM,HT, RF	12	K. pneumoniae	Urine	15/04/2012	None	Deceased
9	65/M	MVR and CABG	Obstructive UTI	11	K. pneumoniae	Urine	18/06/2012	Colistin and meropenem	Recovered

^aM, male; F, female.

^bPVD, peripheral vascular disease; UTI, urinary tract infection; CVA, cerebrovascular accident; CA, cancer; MVR, mitral valve replacement; CABG, coronary arterial bypass graft.

^cDM, diabetes mellitus; HT, hypertension; RF, renal failure.

^dTA, tracheal aspirate.

^eDay/month/year.

^fpt, patient.